14
Participants
Start Date
December 31, 2005
Primary Completion Date
January 31, 2009
Study Completion Date
February 28, 2009
erlotinib
"Levels:~* 1 Erlotinib 50 mg/d~* 2 Erlotinib 50 mg/d~ * 1 Erlotinib 100 mg/d~ * 2 Erlotinib 100 mg/d~ * 3 Erlotinib 150 mg/d~ * 4 Erlotinib 150 mg/d"
RAD001
"Levels~minus 1: RAD001 2.5 mg/d~minus 2: RAD001 2.5 every other day~1. RAD001 2.5 mg per day~2. RAD001 5 mg per day~3. RAD001 10 mg per day~4. RAD001 10 mg per day"
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville
Vanderbilt-Ingram Cancer Center at Franklin, Nashville
Vanderbilt-Ingram Cancer Center, Nashville
National Cancer Institute (NCI)
NIH
Vanderbilt-Ingram Cancer Center
OTHER